AMERICAN AUTOIMMUNE RELATED DISEASES ASSOCIATION

Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$2,931,042
Cash & Equivalents
85%
Other Assets
14%
Receivables (Non-Related)
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Liabilities in 2024 (Year End)
$473,476
Other Liabilities
89%
Payables & Accruals
11%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$2,269,608
$2,491,501
+10%
Receivables (Non-Related)
-
$9,057
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
$15,424
$8,852
-43%
Other Assets
$459,627
$421,632
-8%
Total Assets
$2,744,659
$2,931,042
+7%
Liabilities
2023
2024
Change
Payables & Accruals
$67,784
$51,844
-24%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$459,627
$421,632
-8%
Total Liabilities
$527,411
$473,476
-10%
Net assets
2023
2024
Change
Restricted Net Assets
$267,291
$313,708
+17%
Unrestricted Net Assets
$1,949,957
$2,143,858
+10%
Net assets
2023
2024
Change
Net assets
+$2,217,248
+$2,457,566
+11%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)